par Beghin, Jean-Christophe
;Yombi, Jean-Cyr;Ruelle, Jean;Van Der Linden, Dimitri
Référence Expert opinion on pharmacotherapy, 19, 1, page (27-37)
Publication Publié, 2018-01-01
;Yombi, Jean-Cyr;Ruelle, Jean;Van Der Linden, DimitriRéférence Expert opinion on pharmacotherapy, 19, 1, page (27-37)
Publication Publié, 2018-01-01
Article révisé par les pairs
| Résumé : | Current international guidelines recommend to treat all HIV-1 infected patients regardless of CD4 cell count. Despite the remarkable worldwide progress for universal access to antiretroviral during the last decade, the pediatric population remains fragile due to lack of randomized studies, inappropriate antiretroviral formulations, adherence difficulties, drug toxicity and development of resistance. |



